On August 16th 2015, Dr. Amy Hermon-Taylor spoke about the Vaccine and new MAP test at ‘The Crohn’s Infection’ Symposium in Chicago. We are pleased to announce that the videos of her presentations -along with those of co-presenters Dr William Chamberlin, Dr Mike Collins, Dr John Aitken and Mr Patrick McLean (Redhill) – are now available for viewing online. To view the presentations, please click on the links below:
Dr-amy-hermon-taylor diagnostic test
I was very lucky to attend the 12th International Colloquium of Paratuberculosis in Parma, Italy last week and to see my father, Prof. Hermon-Taylor, receive a Lifetime Achievement Award for his work in the field of Mycobacterium avium subspecies paratuberculosis (MAP) and Crohn’s Disease.
There were many interesting presentations from research groups across the world. Perhaps the most sinister report was that on the detection of live MAP in Infant Formula. Scientists from the University of Wisconsin together with Queen’s University, Belfast tested 68 samples of powdered Infant Formula from 18 countries, including 40 brands. 44% (30/68) tested positive for live MAP. Although these findings require further validation, they serve to highlight how important it is that we do not ignore the compelling evidence that MAP causes Crohn’s disease. It is imperative that we resolve this issue, once and for all, by funding a trial of the vaccine that could both prevent and cure this disease.
There is compelling evidence that Crohn’s Disease is caused by a bacteria called Mycobacterium avium subspecies paratuberculosis (MAP). A treatment Vaccine against MAP is ready to go to human trials. This is currently the only treatment on the horizon which offers the hope of a cure for Crohn’s Disease, rather than temporary remission. The issue of whether Crohn’s is caused by MAP has divided the medical community for the last 101 years. For the sake of millions of people who live with the devastating effects of Crohn’s Disease, and their families, we must end the controversy now, either way, by doing a trial of the Crohn’s MAP Vaccine in humans.
Ongoing funding is sought to complete the development of the new MAP test and to support the Crohn’s MAP Vaccine phase 1 human trial, now underway at The Jenner Institute. PLEASE contact us if you are interested in donating towards the new MAP test or investing in the vaccine – and potentially a better life for millions of people currently suffering from Crohn’s Disease.